Literature DB >> 29388008

Biomarkers in Graft-Versus-Host Disease: from Prediction and Diagnosis to Insights into Complex Graft/Host Interactions.

Fiona C He1, Shernan G Holtan2,3.   

Abstract

PURPOSE OF REVIEW: Acute graft versus host disease (aGVHD) is a frequent cause of treatment-related mortality after allogeneic hematopoietic stem cell transplantation (alloHCT), with few effective treatment options beyond systemic steroids. Discovery of biomarkers for aGVHD may provide insight into the pathophysiology of aGVHD and suggest novel mechanisms for treatment. RECENT
FINDINGS: We highlight biomarkers within innate immune activation, T-cell-mediated tissue damage, endothelial damage, dysbiosis, and poor wound healing that can be obtained prior to transplant, in the early transplant period, or at the onset of aGVHD. aGVHD biomarkers have predictive and prognostic utility but also suggest novel mechanisms of recipient tissue damage and impaired regenerative capacity. These mechanisms should be further studied and tested in therapeutic clinical trials to improve outcomes post-alloHCT.

Entities:  

Keywords:  Acute graft versus host disease; Biomarkers; Pathophysiology; Predictive; Prognostic

Mesh:

Substances:

Year:  2018        PMID: 29388008     DOI: 10.1007/s11899-018-0433-2

Source DB:  PubMed          Journal:  Curr Hematol Malig Rep        ISSN: 1558-8211            Impact factor:   4.213


  60 in total

1.  Plasma biomarkers of lower gastrointestinal and liver acute GVHD.

Authors:  Andrew C Harris; James L M Ferrara; Thomas M Braun; Ernst Holler; Takanori Teshima; John E Levine; Sung W Choi; Karin Landfried; Koichi Akashi; Mark Vander Lugt; Daniel R Couriel; Pavan Reddy; Sophie Paczesny
Journal:  Blood       Date:  2012-01-27       Impact factor: 22.113

2.  Citrulline and Monocyte-Derived Macrophage Reactivity before Conditioning Predict Acute Graft-versus-Host Disease.

Authors:  Thomas Hueso; Valérie Coiteux; Marie Joncquel Chevalier Curt; Julien Labreuche; Thierry Jouault; Ibrahim Yakoub-Agha; David Seguy
Journal:  Biol Blood Marrow Transplant       Date:  2017-03-02       Impact factor: 5.742

3.  Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

Authors:  Madan Jagasia; Mukta Arora; Mary E D Flowers; Nelson J Chao; Philip L McCarthy; Corey S Cutler; Alvaro Urbano-Ispizua; Steven Z Pavletic; Michael D Haagenson; Mei-Jie Zhang; Joseph H Antin; Brian J Bolwell; Christopher Bredeson; Jean-Yves Cahn; Mitchell Cairo; Robert Peter Gale; Vikas Gupta; Stephanie J Lee; Mark Litzow; Daniel J Weisdorf; Mary M Horowitz; Theresa Hahn
Journal:  Blood       Date:  2011-10-18       Impact factor: 22.113

4.  Circulating angiogenic factors associated with response and survival in patients with acute graft-versus-host disease: results from Blood and Marrow Transplant Clinical Trials Network 0302 and 0802.

Authors:  Shernan G Holtan; Michael R Verneris; Kirk R Schultz; Laura F Newell; Gabrielle Meyers; Fiona He; Todd E DeFor; Gregory M Vercellotti; Arne Slungaard; Margaret L MacMillan; Sarah A Cooley; Bruce R Blazar; Angela Panoskaltsis-Mortari; Daniel J Weisdorf
Journal:  Biol Blood Marrow Transplant       Date:  2015-03-07       Impact factor: 5.742

5.  Low day +100 serum epidermal growth factor levels are associated with acute GvHD after allogeneic hematopoietic cell transplantation.

Authors:  F He; M R Verneris; S Cooley; B R Blazar; M L MacMillan; L F Newell; A Panoskaltsis-Mortari; T DeFor; D J Weisdorf; S G Holtan
Journal:  Bone Marrow Transplant       Date:  2016-11-21       Impact factor: 5.483

6.  Effectiveness of donor natural killer cell alloreactivity in mismatched hematopoietic transplants.

Authors:  Loredana Ruggeri; Marusca Capanni; Elena Urbani; Katia Perruccio; Warren D Shlomchik; Antonella Tosti; Sabrina Posati; Daniela Rogaia; Francesco Frassoni; Franco Aversa; Massimo F Martelli; Andrea Velardi
Journal:  Science       Date:  2002-03-15       Impact factor: 47.728

7.  Plasma microRNA signature as a noninvasive biomarker for acute graft-versus-host disease.

Authors:  Bin Xiao; Yu Wang; Wei Li; Megan Baker; Jian Guo; Kelly Corbet; Ephraim L Tsalik; Qi-Jing Li; Scott M Palmer; Christopher W Woods; Zhiguo Li; Nelson J Chao; You-Wen He
Journal:  Blood       Date:  2013-09-16       Impact factor: 22.113

8.  Response of 443 patients to steroids as primary therapy for acute graft-versus-host disease: comparison of grading systems.

Authors:  Margaret L MacMillan; Daniel J Weisdorf; John E Wagner; Todd E DeFor; Linda J Burns; Norma K C Ramsay; Stella M Davies; Bruce R Blazar
Journal:  Biol Blood Marrow Transplant       Date:  2002       Impact factor: 5.742

9.  ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death.

Authors:  Mark T Vander Lugt; Thomas M Braun; Samir Hanash; Jerome Ritz; Vincent T Ho; Joseph H Antin; Qing Zhang; Chee-Hong Wong; Hong Wang; Alice Chin; Aurélie Gomez; Andrew C Harris; John E Levine; Sung W Choi; Daniel Couriel; Pavan Reddy; James L M Ferrara; Sophie Paczesny
Journal:  N Engl J Med       Date:  2013-08-08       Impact factor: 91.245

10.  Post-Transplantation Natural Killer Cell Count: A Predictor of Acute Graft-Versus-Host Disease and Survival Outcomes After Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Seo Yeon Kim; Hyewon Lee; Mi-Soon Han; Hyoeun Shim; Hyeon-Seok Eom; Boram Park; Sun-Young Kong
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-06-08
View more
  6 in total

1.  A panel of 4 biomarkers for the early diagnosis and therapeutic efficacy of aGVHD.

Authors:  Xiaoping Li; Ting Chen; Qiangguo Gao; Wei Zhang; Yunshuo Xiao; Wen Zhu; Lingyu Zeng; Zhenyu Li; Shijie Yang; Rui Wang; Xiaoqi Wang; Yimei Feng; Xi Zhang
Journal:  JCI Insight       Date:  2019-08-22

2.  Real-time, personalized medicine through wearable sensors and dynamic predictive modeling: a new paradigm for clinical medicine.

Authors:  Jonathan Tyler; Sung Won Choi; Muneesh Tewari
Journal:  Curr Opin Syst Biol       Date:  2020-07-07

3.  Application of latent class analysis in diagnosis of graft-versus-host disease by serum markers after allogeneic haematopoietic stem cell transplantation.

Authors:  Maedeh Amini; Anoshirvan Kazemnejad; Aliakbar Rasekhi; Farid Zayeri; Abbas Hajifathali; Farzaneh Tavakoli
Journal:  Sci Rep       Date:  2020-02-27       Impact factor: 4.379

4.  Association of Pre-Transplant Angiopoietin-2 Index with the Risk of Acute Graft-Versus-Host Disease after Hematopoietic Stem Cell Transplantation

Authors:  Özlem Satırer; İnci Cevher Zeytin; Berna Alkan; Jale Karakaya; Duygu Çetinkaya; Fatma Visal Okur
Journal:  Turk J Haematol       Date:  2021-10-07       Impact factor: 1.831

5.  Activated CD4 + T lymphocyte is a potential biomarker for acute graft-vs.-host disease after hematopoietic stem cell transplantation in children with transfusion-dependent β-thalassemia.

Authors:  Ken Huang; Jianming Luo
Journal:  Front Pediatr       Date:  2022-09-29       Impact factor: 3.569

Review 6.  Treatment and unmet needs in steroid-refractory acute graft-versus-host disease.

Authors:  Florent Malard; Xiao-Jun Huang; Joycelyn P Y Sim
Journal:  Leukemia       Date:  2020-04-03       Impact factor: 11.528

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.